Log In
Print this Print this

oltipraz (CB1400)

  Manage Alerts
Collapse Summary General Information
Company Canopus BioPharma Inc.
DescriptionOral dithiolethione agent
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationLung cancer
Indication DetailsTreat lung cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today